Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-004232
Filing Date
2021-04-05
Accepted
2021-04-05 17:27:29
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1699640
2 GRAPHIC g143204g01a22.jpg GRAPHIC 121750
3 GRAPHIC g143204g06h26.jpg GRAPHIC 135700
4 GRAPHIC g143204g06u22.jpg GRAPHIC 157279
5 GRAPHIC g143204g07h27.jpg GRAPHIC 60503
6 GRAPHIC g143204g09a22.jpg GRAPHIC 96757
7 GRAPHIC g143204g09i77.jpg GRAPHIC 133444
8 GRAPHIC g143204g10b30.jpg GRAPHIC 52982
9 GRAPHIC g143204g32n74.jpg GRAPHIC 96983
10 GRAPHIC g143204g50a89.jpg GRAPHIC 104549
11 GRAPHIC g143204g50e23.jpg GRAPHIC 101943
12 GRAPHIC g143204g53b41.jpg GRAPHIC 225267
13 GRAPHIC g143204g57u15.jpg GRAPHIC 48344
14 GRAPHIC g143204g63j52.jpg GRAPHIC 137575
15 GRAPHIC g143204g85i23.jpg GRAPHIC 48303
  Complete submission text file 0000950123-21-004232.txt   3791440
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
Type: DRS | Act: 33 | File No.: 377-04594 | Film No.: 21806771
SIC: 2834 Pharmaceutical Preparations